Who invested in LiPlasome Pharma?
LiPlasome Pharma's investors include Vecata, BankInvest Biomedical Venture and Incuba Venture.
Denmark · Series B startup
Funding summaryUpdated 26 Oct 2026
$8.0Mraised across 1 round since 2005, from 1 source
LiPlasome Pharma's investors include Vecata, BankInvest Biomedical Venture and Incuba Venture.
LiPlasome Pharma has raised $8.0M across 1 round since 2005.
LiPlasome Pharma's most recent round was a Series B of $8.0M in Mar 2005.
Its most recent round, $8.0M in Mar 2005, is also its largest on record.
LiPlasome Pharma's first round on record, in Mar 2005, was backed by Vecata, BankInvest Biomedical Venture and Incuba Venture.
LiPlasome Pharma's latest named round is a Series B, in Mar 2005.
LiPlasome Pharma is based in Denmark.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.